Fowler T, Edeghere O, Inglis N, Bradshaw S
Unit of Urologic and Genetic Epidemiology, Department of Public Health, Epidemiology & Biostatistics, The University of Birmingham, Birmingham B15 2TT, UK.
Int J STD AIDS. 2013 Mar;24(3):185-91. doi: 10.1177/0956462412472443. Epub 2013 May 6.
Advances in technology have raised the possibility of including gonorrhoea testing as part of chlamydia screening. In England this is recommended only where the positive predictive value (PPV) of the test is ≥90%. This study assessed the PPV for gonorrhoea testing using routine testing data. Routine data (including gonorrhoea testing) from the Greater Manchester Chlamydia Screening Programme (GMCSP) in 2009/2010, were used to estimate the PPV for gonorrhoea testing. Of those screened, 0.3% (59/18044) of men and 0.4% (174/41873) of women tested positive for gonorrhoea. The PPV was 82.3% in women and 73.6% in men, in those who also tested positive for chlamydia. For women and men testing negative for chlamydia the PPV for a positive gonorrhoea test was incalculable. The low PPV observed in most groups suggests that where population testing for gonorrhoea occurs there is a need for further confirmatory testing of positive results before treatment decisions are made. Clinicians should be aware of screening test result limitations in this context.
技术进步增加了将淋病检测纳入衣原体筛查的可能性。在英格兰,仅在检测的阳性预测值(PPV)≥90%时才推荐这样做。本研究使用常规检测数据评估淋病检测的PPV。利用2009/2010年大曼彻斯特衣原体筛查项目(GMCSP)的常规数据(包括淋病检测)来估计淋病检测的PPV。在接受筛查的人群中,0.3%(59/18044)的男性和0.4%(174/41873)的女性淋病检测呈阳性。在衣原体检测也呈阳性的人群中,女性的PPV为82.3%,男性为73.6%。对于衣原体检测呈阴性的女性和男性,淋病检测阳性的PPV无法计算。在大多数人群中观察到的低PPV表明,在进行人群淋病检测时,在做出治疗决定之前,需要对阳性结果进行进一步的确认检测。临床医生在这种情况下应意识到筛查检测结果的局限性。